Literature DB >> 12615237

Capillary electrophoresis determination of loratadine and related impurities.

H Fernández1, F J Rupérez, C Barbas.   

Abstract

While HPLC has traditionally been the method of choice for purity determination of pharmaceutical substances, capillary electrophoresis (CE) offers a different selectivity and hence it is a complementary technique to HPLC. Loratadine, an antihistamine, could include in its raw material seven impurities that ought to be separated, identified and quantified for drug development and quality control. As a complementary tool for undoubtful identification, a CE method has been developed. The separation was carried out with an uncoated fused-silica capillary (57 cm x 50 microm ID) and was operated at 20 kV potential. Temperature was maintained at 25 degrees C. The final separation buffer was prepared with 100 mM H(3)PO(4) made up to pH 2.5 with NaOH and with 10% acetonitrile added (v/v). Impurities can be detected at the 0.1% level of the active and validation parameters for linearity accuracy and precision are adequate for all the analytes and that permits to consider the method reliable and suitable for application to long-term stability and purity studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615237     DOI: 10.1016/s0731-7085(02)00668-4

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Simultaneous determination of loratadine, desloratadine and cetirizine by capillary zone electrophoresis.

Authors:  Gabriel Hancu; Camelia Campian; Aura Rusu; Eleonora Mircia; Hajnal Kelemen
Journal:  Adv Pharm Bull       Date:  2013-12-24

2.  UV-Vis Spectrophotometry and Multivariate Calibration Method for Simultaneous Determination of Theophylline, Montelukast and Loratadine in Tablet Preparations and Spiked Human Plasma.

Authors:  Seyed Karim Hassaninejad-Darzi; Abdolraouf Samadi-Maybodi; Seyed Mohsen Nikou
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.